222 related articles for article (PubMed ID: 24483160)
1. Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes.
El-Khatib FH; Russell SJ; Magyar KL; Sinha M; McKeon K; Nathan DM; Damiano ER
J Clin Endocrinol Metab; 2014 May; 99(5):1701-11. PubMed ID: 24483160
[TBL] [Abstract][Full Text] [Related]
2. Outpatient glycemic control with a bionic pancreas in type 1 diabetes.
Russell SJ; El-Khatib FH; Sinha M; Magyar KL; McKeon K; Goergen LG; Balliro C; Hillard MA; Nathan DM; Damiano ER
N Engl J Med; 2014 Jul; 371(4):313-325. PubMed ID: 24931572
[TBL] [Abstract][Full Text] [Related]
3. Enhancing automatic closed-loop glucose control in type 1 diabetes with an adaptive meal bolus calculator - in silico evaluation under intra-day variability.
Herrero P; Bondia J; Adewuyi O; Pesl P; El-Sharkawy M; Reddy M; Toumazou C; Oliver N; Georgiou P
Comput Methods Programs Biomed; 2017 Jul; 146():125-131. PubMed ID: 28688482
[TBL] [Abstract][Full Text] [Related]
4. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.
El-Khatib FH; Balliro C; Hillard MA; Magyar KL; Ekhlaspour L; Sinha M; Mondesir D; Esmaeili A; Hartigan C; Thompson MJ; Malkani S; Lock JP; Harlan DM; Clinton P; Frank E; Wilson DM; DeSalvo D; Norlander L; Ly T; Buckingham BA; Diner J; Dezube M; Young LA; Goley A; Kirkman MS; Buse JB; Zheng H; Selagamsetty RR; Damiano ER; Russell SJ
Lancet; 2017 Jan; 389(10067):369-380. PubMed ID: 28007348
[TBL] [Abstract][Full Text] [Related]
5. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
[TBL] [Abstract][Full Text] [Related]
6. Blood glucose control in type 1 diabetes with a bihormonal bionic endocrine pancreas.
Russell SJ; El-Khatib FH; Nathan DM; Magyar KL; Jiang J; Damiano ER
Diabetes Care; 2012 Nov; 35(11):2148-55. PubMed ID: 22923666
[TBL] [Abstract][Full Text] [Related]
7. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.
Russell SJ; Hillard MA; Balliro C; Magyar KL; Selagamsetty R; Sinha M; Grennan K; Mondesir D; Ekhlaspour L; Zheng H; Damiano ER; El-Khatib FH
Lancet Diabetes Endocrinol; 2016 Mar; 4(3):233-243. PubMed ID: 26850709
[TBL] [Abstract][Full Text] [Related]
8. Feasibility Studies of an Insulin-Only Bionic Pancreas in a Home-Use Setting.
Ekhlaspour L; Nally LM; El-Khatib FH; Ly TT; Clinton P; Frank E; Tanenbaum ML; Hanes SJ; Selagamsetty RR; Hood K; Damiano ER; Buckingham BA
J Diabetes Sci Technol; 2019 Nov; 13(6):1001-1007. PubMed ID: 31470740
[TBL] [Abstract][Full Text] [Related]
9. Performance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 Diabetes.
Buckingham BA; Christiansen MP; Forlenza GP; Wadwa RP; Peyser TA; Lee JB; O'Connor J; Dassau E; Huyett LM; Layne JE; Ly TT
Diabetes Technol Ther; 2018 Sep; 20(9):585-595. PubMed ID: 30070928
[TBL] [Abstract][Full Text] [Related]
10. Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target.
Rossetti P; Quirós C; Moscardó V; Comas A; Giménez M; Ampudia-Blasco FJ; León F; Montaser E; Conget I; Bondia J; Vehí J
Diabetes Technol Ther; 2017 Jun; 19(6):355-362. PubMed ID: 28459603
[TBL] [Abstract][Full Text] [Related]
11. A Meal Detection Algorithm for the Artificial Pancreas: A Randomized Controlled Clinical Trial in Adolescents With Type 1 Diabetes.
Palisaitis E; El Fathi A; von Oettingen JE; Haidar A; Legault L
Diabetes Care; 2021 Feb; 44(2):604-606. PubMed ID: 33277302
[TBL] [Abstract][Full Text] [Related]
12. Artificial Pancreas: Clinical Study in Latin America Without Premeal Insulin Boluses.
Sánchez-Peña R; Colmegna P; Garelli F; De Battista H; García-Violini D; Moscoso-Vásquez M; Rosales N; Fushimi E; Campos-Náñez E; Breton M; Beruto V; Scibona P; Rodriguez C; Giunta J; Simonovich V; Belloso WH; Cherñavvsky D; Grosembacher L
J Diabetes Sci Technol; 2018 Sep; 12(5):914-925. PubMed ID: 29998754
[TBL] [Abstract][Full Text] [Related]
13. Fully Automated Artificial Pancreas for Adults With Type 1 Diabetes Using Multiple Hormones: Exploratory Experiments.
Majdpour D; Tsoukas MA; Yale JF; El Fathi A; Rutkowski J; Rene J; Garfield N; Legault L; Haidar A
Can J Diabetes; 2021 Dec; 45(8):734-742. PubMed ID: 33888413
[TBL] [Abstract][Full Text] [Related]
14. Adaptive Control of an Artificial Pancreas Using Model Identification, Adaptive Postprandial Insulin Delivery, and Heart Rate and Accelerometry as Control Inputs.
Resalat N; Hilts W; Youssef JE; Tyler N; Castle JR; Jacobs PG
J Diabetes Sci Technol; 2019 Nov; 13(6):1044-1053. PubMed ID: 31595784
[TBL] [Abstract][Full Text] [Related]
15. Performance of Omnipod Personalized Model Predictive Control Algorithm with Moderate Intensity Exercise in Adults with Type 1 Diabetes.
Forlenza GP; Buckingham BA; Christiansen MP; Wadwa RP; Peyser TA; Lee JB; O'Connor J; Dassau E; Huyett LM; Layne JE; Ly TT
Diabetes Technol Ther; 2019 May; 21(5):265-272. PubMed ID: 30925077
[No Abstract] [Full Text] [Related]
16. Fully Closed-Loop Multiple Model Probabilistic Predictive Controller Artificial Pancreas Performance in Adolescents and Adults in a Supervised Hotel Setting.
Forlenza GP; Cameron FM; Ly TT; Lam D; Howsmon DP; Baysal N; Kulina G; Messer L; Clinton P; Levister C; Patek SD; Levy CJ; Wadwa RP; Maahs DM; Bequette BW; Buckingham BA
Diabetes Technol Ther; 2018 May; 20(5):335-343. PubMed ID: 29658779
[TBL] [Abstract][Full Text] [Related]
17. Performance of the Insulin-Only iLet Bionic Pancreas and the Bihormonal iLet Using Dasiglucagon in Adults With Type 1 Diabetes in a Home-Use Setting.
Castellanos LE; Balliro CA; Sherwood JS; Jafri R; Hillard MA; Greaux E; Selagamsetty R; Zheng H; El-Khatib FH; Damiano ER; Russell SJ
Diabetes Care; 2021 Jun; 44(6):e118-e120. PubMed ID: 33906916
[No Abstract] [Full Text] [Related]
18. An In Silico Head-to-Head Comparison of the Do-It-Yourself Artificial Pancreas Loop and Bio-Inspired Artificial Pancreas Control Algorithms.
Armiger R; Reddy M; Oliver NS; Georgiou P; Herrero P
J Diabetes Sci Technol; 2022 Jan; 16(1):29-39. PubMed ID: 34861785
[TBL] [Abstract][Full Text] [Related]
19. Utility and Safety of Backup Insulin Regimens Generated by the Bionic Pancreas: A Randomized Study.
Mauras N; Damiano ER; El-Khatib FH; Marak MC; Calhoun P; Ruedy KJ; Balliro C; Li Z; Beck RW; Russell SJ
Diabetes Technol Ther; 2023 Jun; 25(6):437-441. PubMed ID: 36877259
[TBL] [Abstract][Full Text] [Related]
20. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
